Suchergebnisse - "Zerbit, Jeremie"

PubPharm (18)

11

Plasma Concentrations and Safety of Lopinavir/Ritonavir in COVID-19 Patients

enthalten in: Therapeutic drug monitoring | 2021

von Chouchana, L. | Boujaafar, S. | Gana, I. | +13

12

Plasma concentration and safety of lopinavir/ritonavir in patients with Covid-19: a short communication

enthalten in: bioRxiv.org | 2020

von Chouchana, L. | Boujaafar, S. | Gana, I. | +12

13

Cancer, immune suppression and Coronavirus Disease-19 (COVID-19) : Need to manage drug safety (French Society for Oncology Pharmacy [SFPO] guidelines)

enthalten in: Cancer treatment reviews | 2020

von Slimano, F. | Baudouin, A. | Zerbit, J. | +12

14

How COVID-19 pandemic has changed haematological care

enthalten in: ResearchSquare.com | 2020

von Fouquet, G. | Franchi, P. | Mittaine-Marzac, B. | +12

15

Improved time to treatment failure and survival in ibrutinib-treated malignancies with a pharmaceutical care program : an observational cohort study

enthalten in: Annals of hematology | 2020

von Zerbit, J. | Chevret, S. | Bernard, S. | +6

16

Improved time to treatment failure and survival in ibrutinib-treated malignancies with a pharmaceutical care program: an observational cohort study

enthalten in: Annals of hematology | 2020

von Zerbit, J. | Chevret, S. | Bernard, S. | +6

17

Improved time to treatment failure and survival in ibrutinib-treated malignancies with a pharmaceutical care program: an observational cohort study

enthalten in: Annals of hematology | 2020

von Zerbit, J. | Chevret, S. | Bernard, S. | +6

18

Improved time to treatment failure and survival in ibrutinib-treated malignancies with a pharmaceutical care program: an observational cohort study

enthalten in: Annals of hematology | 2020

von Zerbit, J. | Chevret, S. | Bernard, S. | +6